Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

<< Previous

Bullboard Posts

Next >>

Comment by 2b7f6fabon Apr 26, 2023 10:40pm

137 Views

Post# 35416133

RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

There's been too much vetching on this board the past couple of months.

Again the belly aching begins because some can't fathom the response numbers..

Y can't people relax and be more zen like?

Consider the TR percentages as ball park figures.

Don't get all caught up in the minutia.

CAN YOU SAY HOLY EXCREMENT BATMAN, DID YOU SEE THOSE TR PERCENTAGES?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec